Mache Seibel discusses the benefits of taking estrogen supplements for women who harbor the BRCA genetic mutation.
For many patients with early-stage breast cancer, these drugs provide a significant boost to disease-free survival.
Laura Yeager talks about her journey with breast cancer, from the fearful thoughts to the free food at chemotherapy.
The Outlook is Hopeful that Biosimilars will Mimic Effectiveness of Original Cancer Drugs for Less Money
Biosimilars are changing the field — and the price — of cancer treatment, though some questions still remain.
Extending hormonal therapy to 10 years has been found to reduce recurrence in HR-positive breast cancer.
In some cases, genomic blood analysis may be effective enough to replace cancer biopsies.
Biosimilars are likely to rival name-brand treatments for breast and other cancers, and the competition could drive prices down.
Androgen deprivation therapy may be linked to dementia in men with prostate cancer, according to a recent study.
The FDA approved Keytruda to treat metastatic non-small cell lung cancer in the frontline setting.